Gian Ussia

Showing 1-12 of 12 articles

Author Sameer Gafoor

Interventions for valvular disease

Gender in the ACCESS-EU registry: a prospective, multicentre, non-randomised post-market approval study of MitraClip® therapy in Europe

Gafoor S, Sievert H, Maisano F, Baldus S, Schäfer U, Hausleiter J, Butter C, Ussia G, Geist V, Widder J, Moccetti T, Schillinger W, Franzen O

June 10, 2016 | 10.4244/EIJV12I2A40

Author Martine Gilard

Interventions for valvular disease

The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes

Gilard M, Schlüter M, Snow T, Dall’Ara G, Eltchaninoff H, Moat N, Goicolea J, Ussia G, Kala P, Wenaweser P, Zembala M, Nickenig G, Price S, Barrero E, Iung B, Zamorano P, Schuler G, Corti R, Alfieri O, Prendergast B, Ludman P, Windecker S, Sabaté M, Witkowski A, Danenberg H, Schroeder E, Romeo F, Macaya C, Derumeaux G, Laroche C, Pighi M, Serdoz R, Di Mario C

May 16, 2016 | 10.4244/EIJV12I1A15

Author Gian Ussia

Interventions for valvular disease

Percutaneous transfemoral-transseptal implantation of a second-generation CardiAQ™ mitral valve bioprosthesis: first procedure description and 30-day follow-up

Ussia G, Quadri A, Cammalleri V, De Vico P, Muscoli S, Marchei M, Ruvolo G, Søndergaard L, Romeo F

February 19, 2016 | 10.4244/EIJY15M09_01

Author Lars Søndergaard

Interventions for valvular disease

The CardiAQ transcatheter mitral valve implantation system

Søndergaard L, Ussia G, Dumonteil N, Quadri A

September 17, 2015 | 10.4244/EIJV11SWA22

Author Gian Ussia

Clinical results with the 31 mm CoreValve™ in large aortic annuli: the importance of implantation technique

Ussia G, Sarkar K, Cammalleri V, Marchei M, Muscoli S, De Vico P, Rubino D, De Persis F, Macrini M, Romeo F

January 22, 2015 | 10.4244/EIJV10I9A182

Author Luca Testa

CoreValve implantation for severe aortic regurgitation: a multicentre registry

Testa L, Latib A, Rossi M, De Marco F, De Carlo M, Fiorina C, Oreglia J, Petronio A, Ettori F, De Servi S, Klugmann S, Ussia G, Tamburino C, Panisi P, Brambilla N, Colombo A, Presbitero P, Bedogni F

October 20, 2014 | 10.4244/EIJV10I6A127

Author Fabrizio D’ascenzo

Gender differences in patients undergoing TAVI: a multicentre study

D’ascenzo F, Gonella A, Moretti C, Omedè P, Salizzoni S, La Torre M, Giordana F, Barbanti M, Ussia G, Brambilla N, Bedogni F, Gaita F, Tamburino C, Sheiban I

July 26, 2013 | 10.4244/EIJV9I3A59

Author Carlo Di Mario

The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients

Di Mario C, Eltchaninoff H, Moat N, Goicolea J, Ussia G, Kala P, Wenaweser P, Zembala M, Nickenig G, Barrero E, Snow T, Iung B, Zamorano P, Schuler G, Corti R, Alfieri O, Prendergast B, Ludman P, Windecker S, Sabaté M, Gilard M, Witkowski A, Danenberg H, Schröder E, Romeo F, Macaya C, Derumeaux G, Maggioni A, Tavazzi L

April 19, 2013 | 10.4244/EIJV8I12A209

Author Gian Ussia

Transcatheter aortic bioprosthesis dislocation: technical aspects and midterm follow-up

Ussia G, Barbanti M, Sarkar K, Aruta P, Scarabelli M, Cammalleri V, Imme S, Pistritto A, Gulino S, Mulè M, Deste W, Cannata S, Tamburino C

March 21, 2012 | 10.4244/EIJV7I11A203

Author Corrado Tamburino

Safety and effectiveness of the Catania Polyzene-F coated stent in real world clinical practice: 12-month results from the ATLANTA 2 registry

Tamburino C, Capodanno D, Di Salvo M-E, Sanfilippo A, Cascone I, Incardona V, Longo G, Giacoppo D, Capranzano P, Sgroi C, Ussia G, Monaco A, La Manna A

January 20, 2012 | 10.4244/EIJV7I9A169

Author Gian Ussia

Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis

Ussia G, Barbanti M, Cammalleri V, Scarabelli M, Mulè M, Aruta P, Pistritto A, Imme S, Capodanno D, Sarkar K, Gulino S, Tamburino C

September 30, 2011 | 10.4244/EIJV7I5A93

Author Nicolo Piazza

Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve ReValving System: results from the multicentre, expanded evaluation registry 1-year following CE mark approval

Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde J-C, de Jaegere P, Serruys P

August 20, 2008

1

Latest news

Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue

(Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right))

December 6, 2019

The challenge of innovation for the (interventional?) cardiology world

December 6, 2019

New this week: A Dose-response Meta Analysis, stroke after MitraClip and more

December 10, 2019

New update! Discover 17 new trials

(The Trials book is supported by Biotronik)

October 29, 2019

Guidance Papers

Guidelines, consensus & position papers

2019 – A leap year for valvular heart disease

(Course directors PCR London Valves 2019)

November 15, 2019

Last week's JAA's: EXTREME Study, Stent Optimization and more

December 3, 2019

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke